StemCell Institute Inc. (7096) Cash flow
Market cap
¥6.9B
P/E ratio
65.2x
Stemcell Research Institute stores umbilical cord blood and tissue for expecting families, preserving stem cells for potential future medical treatments.
| 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 35 | 32 | 33 | 97 | 105 | 121 | 128 | 157 |
| Cash from operations | 391 | 668 | 239 | 469 | 100 | 335 | 468 | 74 |
| Capital expenditures | -29 | -59 | -401 | -181 | -56 | -183 | -478 | -409 |
| Cash from investing | -184 | -108 | -520 | 404 | -285 | -812 | -259 | -745 |
| Payments for dividends | - | - | - | - | - | - | -256 | -0 |
| Repurchases of common stock | - | - | - | - | -0 | - | -94 | -106 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | 510 | - |
| Repayments of term debt | - | - | - | - | - | - | -10 | -63 |
| Cash from financing | - | - | - | 644 | -1 | -1 | 147 | 232 |